...
首页> 外文期刊>Analytical and bioanalytical chemistry >Targeting human c-Myc promoter duplex DNA with actinomycin D by use of multi-way analysis of quantum-dot-mediated fluorescence resonance energy transfer
【24h】

Targeting human c-Myc promoter duplex DNA with actinomycin D by use of multi-way analysis of quantum-dot-mediated fluorescence resonance energy transfer

机译:通过使用多点分析量子点介导的荧光共振能量转移,用放线菌素D靶向人c-Myc启动子双链DNA

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Actinomycin D (Act D), an oncogenic c-Myc promoter binder, interferes with the action of RNA polymerase. There is great demand for high-throughput technology able to monitor the activity of DNA-binding drugs. To this end, binding of 7-aminoactinomycin D (7AAD) to the duplex c-Myc promoter was investigated by use of 2D-photoluminescence emission (2D-PLE), and the resulting data were subjected to analysis by use of convenient and powerful multi-way approaches. Fluorescence measurements were performed by use of the quantum dot (QD)-conjugated c-Myc promoter. Intercalation of 7AAD within duplex base pairs resulted in efficient energy transfer from drug to QD via fluorescence resonance energy transfer (FRET). Multi-way analysis of the three-way data array obtained from titration experiments was performed by use of restricted Tucker3 and hard trilinear decomposition (HTD). These techniques enable analysis of high-dimensional and complex data from nanobiological systems which include several spectrally overlapped structures. It was almost impossible to obtain robust and meaningful information about the FRET process for such high overlap data by use of classical analysis. The soft approach had the important advantage over univariate classical methods of enabling us to investigate the source of variance in the fluorescence signal of the DNA-drug complex. It was established that hard trilinear decomposition analysis of FRET-measured data overcomes the problem of rank deficiency, enabling calculation of concentration profiles and pure spectra for all species, including non-fluorophores. The hard modeling approach was also used for determination of equilibrium constants for the hybridization and intercalation equilibria, using nonlinear fit data analysis. The intercalation constant 3.6 × 10~6 mol~(-1) L and hybridization stability 1.0 × 10~8 mol~(-1) L obtained were in good agreement with values reported in the literature. The analytical concentration of the QD-labeled DNA was determined by use of nonlinear fitting, without using external standard calibration samples. This study was a successful application of multi-way chemometric methods to investigation of nano-biotechnological systems where several overlapped species coexist in solution. [Figure not available: see fulltext.]
机译:放线菌素D(Act D)是一种致癌性c-Myc启动子结合剂,干扰RNA聚合酶的作用。对能够监控DNA结合药物活性的高通量技术的需求很大。为此,使用2D光致发光发射(2D-PLE)研究了7-氨基放线菌素D(7AAD)与双链c-Myc启动子的结合,并使用方便而强大的多分子分析技术对所得数据进行了分析。方式。荧光测量是通过使用量子点(QD)共轭的c-Myc启动子进行的。在双链碱基对中插入7AAD导致通过荧光共振能量转移(FRET)从药物到QD的有效能量转移。通过使用受限的Tucker3和硬三线性分解(HTD)对从滴定实验获得的三向数据阵列进行多向分析。这些技术使得能够分析来自包括多个光谱重叠结构的纳米生物学系统的高维和复杂数据。通过经典分析,对于如此高的重叠数据,几乎不可能获得有关FRET过程的可靠且有意义的信息。与单变量经典方法相比,软方法具有重要的优势,它使我们能够研究DNA药物复合物的荧光信号的方差来源。已经确定,对FRET测得的数据进行硬三线性分解分析可以克服等级不足的问题,从而可以计算所有物种(包括非荧光团)的浓度分布图和纯光谱。硬建模方法还用于使用非线性拟合数据分析来确定杂交和插入平衡的平衡常数。获得的插层常数为3.6×10〜6 mol〜(-1)L,杂交稳定性为1.0×10〜8 mol〜(-1)L,与文献报道的值相吻合。 QD标记的DNA的分析浓度通过使用非线性拟合确定,而无需使用外部标准校准样品。这项研究是多路化学计量方法在纳米生物技术系统研究中的成功应用,在纳米生物技术系统中,几种重叠物种共存于溶液中。 [图不可用:请参见全文。]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号